Literature DB >> 25102298

Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis.

Hamidreza Maroof1, Ali Salajegheh1, Robert Anthony Smith1, Alfred King-Yin Lam2.   

Abstract

MicroRNA-34 is involved in pathogenesis in cancer by targeting different tumor-related genes. It could be a biomarker for predicting the prognosis of patients with cancer. In addition, miR-34 is involved in the tumor angiogenesis. Understanding the mechanism of the miR-34 in cancer and tumor angiogenesis will open horizons for development of anti-cancer and anti-angiogenesis drugs.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Cancer; miRNA-34

Mesh：

Substances：

Year:  2014        PMID： 25102298     DOI： 10.1016/j.yexmp.2014.08.002

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN： 0014-4800            Impact factor:   3.362


  17 in total

Review 1.  Developing miRNA therapeutics for cardiac repair in ischemic heart disease.

Authors:  Kai Zhu; Dingqian Liu; Hao Lai; Jun Li; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.

Authors:  Yan Zhou; Rui-hua Zhao; Kuo-fu Tseng; Kun-peng Li; Zhi-gang Lu; Yuan Liu; Kun Han; Zhi-hua Gan; Shu-chen Lin; Hai-yan Hu; Da-liu Min
Journal:  Acta Pharmacol Sin       Date:  2016-02-29       Impact factor: 6.150

3.  The roles of microRNA-34b-5p in angiogenesis of thyroid carcinoma.

Authors:  Hamidreza Maroof; Farhadul Islam; Armin Ariana; Vinod Gopalan; Alfred K Lam
Journal:  Endocrine       Date:  2017-08-24       Impact factor: 3.633

4.  miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression.

Authors:  Kun Duan; Yong-Chao Ge; Xue-Pei Zhang; Shu-Yi Wu; Jin-Shun Feng; Shi-Lin Chen; L I Zhang; Zhi-Hao Yuan; Chao-Hong Fu
Journal:  Oncol Lett       Date:  2015-08-26       Impact factor: 2.967

Review 5.  Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.

Authors:  Zhimin Yang; Tang Liu; Xiaolei Ren; Mei Yang; Chao Tu; Zhihong Li
Journal:  Cell Cycle       Date:  2022-06-14       Impact factor: 5.173

6.  Cytotoxicity of Amphotericin B and AmBisome: In Silico and In Vivo Evaluation Employing the Chick Embryo Model.

Authors:  Ahmad Khosravi; Iraj Sharifi; Hadi Tavakkoli; Elaheh Molaakbari; Sina Bahraminegad; Ehsan Salarkia; Fatemeh Seyedi; Alireza Keyhani; Zohreh Salari; Fatemeh Sharifi; Mehdi Bamorovat; Ali Afgar; Shahriar Dabiri
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

7.  RABEX-5 is upregulated and plays an oncogenic role in gastric cancer development by activating the VEGF signaling pathway.

Authors:  Shuang Wang; Aixia Lu; Xiangming Chen; Lin Wei; Jiqiang Ding
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

8.  MicroRNA-34c is regulated by p53 and is involved in sevoflurane-induced apoptosis in the developing rat brain potentially via the mitochondrial pathway.

Authors:  Xue Zhou; Dongfeng Xian; Jiehua Xia; Ying Tang; Wenda Li; Xiaohui Chen; Zhibin Zhou; Dihan Lu; Xia Feng
Journal:  Mol Med Rep       Date:  2017-03-01       Impact factor: 2.952

9.  Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Jia Li; Matthew Lam
Journal:  Elife       Date:  2015-07-31       Impact factor: 8.140

Review 10.  New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Authors:  Erika Larrea; Carla Sole; Lorea Manterola; Ibai Goicoechea; María Armesto; María Arestin; María M Caffarel; Angela M Araujo; María Araiz; Marta Fernandez-Mercado; Charles H Lawrie
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.